Intas Pharmaceuticals Limited Apixaban Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Apixaban Export Records India — #3 Exporter, 436 Shipments, $18.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Apixaban

India Pharmaceutical Trade Intelligence

$179.9M171 Suppliers98 CountriesHS 30049099

ExportsIndia → LEBANON41.8%India → CANADA18.3%

ImportsGERMANY → India$14.0B BELGIUM → India$17.4M

Intas Pharmaceuticals Limited — Apixaban Exporter #3 | $18.7M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Apixaban Exporter Profile

Indian Pharmaceutical Exporter · #3 for Apixaban · $18.7M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #3 Indian exporter of Apixaban with $18.7M in export value and 436 verified shipments. Intas Pharmaceuticals Limited holds a 10.4% market share in Apixaban exports across 9 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Apixaban Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Apixaban export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Apixaban?

Country	Value	Shipments	Share
NETHERLANDS	$3.7M	157	34.1%
BRAZIL	$1.9M	71	17.5%
UNITED KINGDOM	$1.7M	62	16.0%
CANADA	$1.7M	76

Who Are the Top Buyers of Apixaban from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
MYLAN IRELAND LIMITED	NETHERLANDS	$3.0M	126
ACCORD UK	UNITED KINGDOM	$1.6M	57
SANOFI MEDLEY FARMACEUTICA LTDA	BRAZIL	$1.4M	46
TO THE ORDER	PHILIPPINES	$925.5K	34
MYLAN IRELAND LTD	NETHERLANDS	$640.6K	27
NORA PHARMA INC	CANADA	$370.5K	17
LABORATOIRE RIVA INC.,	CANADA	$345.9K	18
LABORATOIRE RIVA INC	CANADA	$324.6K	12
NORA PHARMA INC.	CANADA	$322.2K	10
VIATRIS PHARMACEUTICALS SL	SPAIN	$250.9K	14

Intas Pharmaceuticals Limited supplies Apixaban to 29 buyers globally. The largest buyer is MYLAN IRELAND LIMITED (NETHERLANDS), followed by ACCORD UK (UNITED KINGDOM) and SANOFI MEDLEY FARMACEUTICA LTDA (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Apixaban Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUG&MED: APIXABAN 5MG 4X14T(MYLA	$551.5K	21
PHARMA DRUGS & MEDI APIXABAN 5MG 4X14T(ACCORD-UK AS PER INVOICE	$368.3K	17
PHARMA DRUG&MED: APIXABAN 5MG 4X14TMYLA	$350.7K	13
PHARMA DRUGS & MEDI APIXABANA 5MG 6X10T	$248.1K	7
PHARMA DRUGS & MEDI APIXABANA 5MG 6X10T (SANOFI-BRAZI) AS PER INVOICE	$200.0K	4
PHARMA DRUG&MED: APIXABAN 2.5MG 6X10TMY	$195.4K	7
PHARMA DRUGS AND MEDI NRA-APIXABAN 5MG 1	$195.0K	5
PHARMA DRUGS AND MEDI RIVA-APIXABAN 5MG	$169.8K	4
PHARMA DRUGS & MEDI APIXABANA 2.5MG 6X10T (SANOFI-BRAZI) AS PER INVOICE	$162.1K	8
PHARMA DRUG MED APIXABAN 5MG 2X14T MYLAN UK Each film coated tablet contains Apixaban 5 mg AS PER INV	$150.7K	6

Intas Pharmaceuticals Limited exports 199 distinct Apixaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUG&MED: APIXABAN 5MG 4X14T(MYLA with 21 shipments worth $551.5K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Apixaban Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	INTAS PHARMACEUTICALS LIMITED ★	$18.7M	436	9	$42.8K
2	APOTEX RESEARCH PRIVATE LIMITED	$18.1M	361	2	$50.0K
4	SANDOZ PRIVATE LIMITED	$15.6M	500	8	$31.2K

Intas Pharmaceuticals Limited ranks #3 among 171 Indian Apixaban exporters. Average shipment value of $42.8K compared to the market average of $497.1K. The closest competitors by value are APOTEX RESEARCH PRIVATE LIMITED and SANDOZ PRIVATE LIMITED.

Which Indian Ports Ship Apixaban Exports?

Port	Shipments	% Share
SAHAR AIR	724	16.1%
SAHAR AIR CARGO ACC (INBOM4)	674	15.0%
DELHI AIR CARGO ACC (INDEL4)	607	13.5%
DELHI AIR	364	8.1%
MUNDRA SEA	146	3.3%
Bombay Air	134	3.0%
JNPT/ NHAVA SHEVA SEA	131	2.9%
AHEMDABAD AIR ACC (INAMD4)	129	2.9%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Apixaban Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Apixaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 445 individual customs records matching Intas Pharmaceuticals Limited exporting Apixaban, covering 199 formulations to 9 countries via 29 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 98+ countries, 371+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Apixaban

Apixaban

Intas Pharmaceuticals Limited — Apixaban Exporter Profile

Intas Pharmaceuticals Limited — Apixaban Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Apixaban?

Who Are the Top Buyers of Apixaban from Intas Pharmaceuticals Limited?

What Is India's Total Apixaban Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Apixaban Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Apixaban Exporters?

What Apixaban Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Apixaban to Key Markets

Brazil — ANVISA

United Kingdom — MHRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Apixaban Exporters?

Which Indian Ports Ship Apixaban Exports?

What Other Cardiovascular Products Does Intas Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Apixaban Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Apixaban Export Data from Intas Pharmaceuticals Limited

Apixaban Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source